Krilogy Financial’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Krilogy Financial's REGN Position: Q3 2026 in Review
Krilogy Financial increased its Regeneron Pharmaceuticals (REGN) stake by 32% in Q3 2026, buying an estimated $450K and bringing the position to 2,474 shares worth $1.89M. The position accounts for 0.05% of the portfolio, ranked #273.
Krilogy Financial first reported a position in REGN in Q3 2025 and has held it in 5 quarters since. The position peaked at $1.89M in Q4 2025. 1,432 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- Krilogy Financial held 2,474 shares of Regeneron Pharmaceuticals worth $1.89M as of Q3 2026.
- Krilogy Financial bought 596 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $450K.
- Regeneron Pharmaceuticals made up 0.05% of Krilogy Financial's portfolio in Q3 2026, its #273 holding.
- Krilogy Financial first reported a position in Regeneron Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
- Krilogy Financial's Regeneron Pharmaceuticals position peaked at $1.89M in Q4 2025.
- 1,432 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on Krilogy Financial's 13F filing for Q3 2026, filed 13 Oct 2026.